Latest news with #biosensors
Yahoo
14 hours ago
- Business
- Yahoo
Biosensors Industry Forecast Report 2025-2034 - The U.S. Biosensors Market Thrives Amid Regulatory Challenges with Innovation and Partnerships Fuelling Expansion
The demand for portable biosensors is escalating, notably in Asia-Pacific and Europe, fueled by chronic disease management needs, such as diabetes and cardiovascular monitoring. Industry growth is supported by technological advancements, increased R&D, and strategic collaborations. Biosensors Market Dublin, June 17, 2025 (GLOBE NEWSWIRE) -- The "Biosensors Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to Global Biosensors Market was valued at USD 32.3 billion in 2024 and is estimated to grow at a CAGR of 7.9% to reach USD 68.5 billion by 2034, driven by increasing applications of biosensors across several sectors, particularly healthcare, where they play a crucial role in detecting biological signals. Additionally, the expanding use of biosensors in drug discovery and biomedicine further supports the market's growth. The growing demand for portable biosensors, especially in regions like Asia-Pacific and Europe, alongside technological advancements, is key factor propelling the industry. Another key factor driving the growth of the biosensors market is the increasing prevalence of chronic conditions, such as diabetes and cardiovascular diseases, which require continuous monitoring and management to avoid serious complications. For example, diabetes, if left unmanaged, can lead to severe health issues like kidney failure, stroke, or lower limb amputations. This has led to a growing demand for devices that can offer real-time monitoring of blood glucose levels, allowing patients to take immediate action when necessary. In addition to diabetes, cardiovascular diseases are also on the rise, creating an increasing need for early detection and ongoing management through advanced diagnostic tools like biosensors. These technologies are helping improve patient outcomes by providing timely data that allows for more precise treatment non-wearable biosensor segment accounted for USD 20.7 billion in 2024. These sensors, integrated into diagnostic devices used for point-of-care testing, are valued for their ease of use, high accuracy, and ability to provide immediate results without continuous user interaction. As healthcare providers seek efficient and timely diagnostic tools, the demand for these non-wearable devices is expected to rise. Technological innovations such as improved sensitivity, miniaturization, and digital connectivity enhance their effectiveness and usability in clinical electrochemical biosensor segment holds a substantial share of the market, representing 41.6% share, which was USD 13.4 billion in 2024. These biosensors are widely used in medical devices such as glucose meters for diabetic patients and in systems that monitor cardiac biomarkers and blood gases. The increasing prevalence of chronic conditions, including cardiovascular diseases and diabetes, drives the demand for electrochemical sensors as essential diagnostic States Biosensors Market generated USD 10.2 billion in 2024, driven by the rising number of chronic disease cases, especially diabetes and heart-related conditions. Despite a strict regulatory environment, the U.S. remains a hub for the development, approval, and commercialization of innovative medical technologies, including biosensors. Regulatory bodies like the FDA are increasingly focused on accelerating the approval process for new biosensor technologies, recognizing their critical role in improving healthcare strengthen their position in the market, companies are focusing on innovation and partnerships. Many firms invest heavily in R&D to develop more advanced biosensor technologies with greater sensitivity and precision. Collaborations with healthcare providers and research institutions help in driving innovation. Furthermore, some companies are working to expand their product portfolios to cater to various medical needs, such as disease-specific biosensors and wearable health monitoring devices. Market leaders, such as Thermo Fisher Scientific, Masimo, and Danaher, are adopting these strategies to enhance their market presence and remain competitive in this rapidly growing Market Analysis and Forecast Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape Competitive landscape with Porter's Five Forces and PESTEL analysis Market size, segmentation, and regional forecasts In-depth company profiles, business strategies, financial insights, and SWOT analysis Key Attributes Report Attribute Details No. of Pages 128 Forecast Period 2024-2034 Estimated Market Value (USD) in 2024 $32.3 Billion Forecasted Market Value (USD) by 2034 $68.5 Billion Compound Annual Growth Rate 7.9% Regions Covered Global Key Topics Covered Chapter 1 Methodology and ScopeChapter 2 Executive Summary2.1 Industry 360 degree synopsisChapter 3 Industry Insights3.1 Industry ecosystem analysis3.2 Industry impact forces3.2.1 Growth drivers3.2.1.1 Growing application of biosensors in medical field3.2.1.2 Rising prevalence of diabetes globally3.2.1.3 High demand for portable biosensors in Asia-Pacific and Europe3.2.1.4 Increasing technological advancements3.2.2 Industry pitfalls and challenges3.2.2.1 Stringent regulatory scenario3.2.2.2 High cost of product development3.3 Growth potential analysis3.4 Regulatory landscape3.5 Trump administration tariffs3.5.1 Impact on trade3.5.1.1 Trade volume disruptions3.5.1.2 Country-wise response3.5.2 Impact on the industry3.5.2.1 Supply-side impact (Cost of manufacturing)3.5.2.1.1 Price volatility in key materials3.5.2.1.2 Supply chain restructuring3.5.2.1.3 Production cost implications3.5.2.2 Demand-side impact (Cost to consumers)3.5.2.2.1 Price transmission to end markets3.5.2.2.2 Market share dynamics3.5.2.2.3 Consumer response patterns3.5.3 Key companies impacted3.5.4 Strategic industry responses3.5.4.1 Supply chain reconfiguration3.5.4.2 Pricing and product strategies3.5.4.3 Policy engagement3.5.5 Outlook and future considerations3.6 Technological landscape3.7 Future market trends3.8 Gap analysis3.9 Porter's analysis3.10 PESTEL analysisChapter 4 Competitive Landscape, 20244.1 Introduction4.2 Company market share analysis4.3 Company matrix analysis4.4 Competitive analysis of major market players4.5 Competitive positioning matrix4.6 Strategy dashboardChapter 5 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)5.1 Key trends5.2 Wearable5.3 Non-wearableChapter 6 Market Estimates and Forecast, by Technology, 2021-2034 ($ Mn)6.1 Key trends6.2 Electrochemical6.3 Optical6.4 Thermal6.5 Piezoelectric6.6 Other technologiesChapter 7 Market Estimates and Forecast, by Applications, 2021-2034 ($ Mn)7.1 Key trends7.2 Blood glucose testing7.3 Cholesterol testing7.4 Blood gas analysis7.5 Pregnancy testing7.6 Drug discovery7.7 Infectious disease testing7.8 Other applicationsChapter 8 Market Estimates and Forecast, by End Use, 2021-2034 ($ Mn)8.1 Key trends8.2 Point of care testing8.3 Home healthcare diagnostics8.4 Research laboratories8.5 Other end usersChapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)9.1 Key trends9.2 North America9.2.1 U.S.9.2.2 Canada9.3 Europe9.3.1 Germany9.3.2 UK9.3.3 France9.3.4 Spain9.3.5 Italy9.3.6 Russia9.3.7 Switzerland9.4 Asia-Pacific9.4.1 China9.4.2 Japan9.4.3 India9.5 Latin America9.5.1 Brazil9.5.2 Mexico9.6 Middle East and Africa9.6.1 South Africa9.6.2 Saudi Arabia Chapter 10 Company Profiles10.1 Abbott Laboratories10.2 ARKRAY10.3 Bio-Rad Laboratories10.4 Biosensors International Group10.5 Dexcom10.6 Danaher10.7 F. Hoffmann-La Roche10.8 Masimo10.9 Nova Biomedical10.10 Platinum Equity Advisors10.11 PHC Holdings10.12 Pinnacle Technology10.13 Siemens Healthineers10.14 Thermo Fisher Scientific10.15 Trividia HealthFor more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Biosensors Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
14 hours ago
- Science
- Yahoo
UT Tyler engineering professor awarded $500K grant for ‘smart hip' research
TYLER, Texas (KETK) — An assistant mechanical engineering professor from the University of Texas at Tyler received a five-year grant worth over $500,000 on Monday from the National Science Foundation. Firefighters stabilize Longview home hit by vehicle Dr. Alwathiqbellah Ibrahim will use the $525,920 Faculty Development Early Career grant to further research and enhance advanced biosensor hip implants. According to the university, Ibrahim's research focuses on micro-electro-mechanical systems (MEMS) that convert mechanical vibrations into electrical energy, also known as 'smart hips'. 'This project aims to develop a new generation of 'smart' hip implants equipped with tiny sensors that monitor the forces acting on the implant during daily activities, such as walking or running,' Ibrahim said. 'These sensors, which also generate their own power from movement, will send data wirelessly to doctors, allowing for early detection of potential problems like loosening or wear before they become serious.' Nacogdoches traffic signal proposed for removal This technology will be able to power electronic devices with vibrations that come from everyday occurrences including human, vehicle and machine motion. The project also has potential to provide learning opportunities for local students. 'UT Tyler students will gain hands-on experience in designing and testing biomedical devices, while related outreach programs will engage K-12 students and educators, promoting awareness of biomedical innovation and STEM careers,' Ibrahim said. 'By combining technical innovation with impactful education, this work aims to set a new standard for orthopedic implants while fostering a diverse and inclusive pipeline of future engineers.' 57-year-old man arrested for burglary in Longview after alarm activation The university said Ibrahim currently directs the UT Tyler Mechatronics and Energy Harvesting Laboratory, which conducts research that may help many people in the future. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Globe and Mail
a day ago
- Business
- Globe and Mail
Biodefense Market worth $1.81 Billion by 2030, at a CAGR of 15.1%
"Biodefense Market" The Biodefense Market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. The report " Biodefense Market by Technology (GHz-band Wave, Microwave Heating, RF-EMR, Cold Plasma, Gamma, UV), Product (Decontamination (Sterilization Devices, Disinfection Units), Biosensors, AI Surveillance), Application, Region - Global Forecast to 2030" The biodefense market is projected to grow from USD 0.89 billion in 2025 to USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. The biodefense market is driven by increasing bioterrorism, growing geopolitical tensions, biological warfare risks, and advancements in technology. Biodefense encompasses a range of tools and systems designed to detect, prevent, and respond to biological threats, including infectious diseases, bioterrorism, and accidental pathogen releases. These include biosensors, rapid detection platforms, decontamination systems, mobile containment units, and AI-driven surveillance tools. The market for biodefense technology is experiencing strong growth due to increasing global concerns over pandemics, biological warfare, and emerging infectious diseases. Download PDF Brochure @ Browse 196 market data Tables and 56 Figures spread through 217 Pages and in-depth TOC on "Biodefense Market" Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the biodefense market during the forecast period. Based on application, the hospitals & medical institutes segment is expected to account for the largest share of the Biodefense Industry during the forecast period. Hospitals are the initial point of contact for the identification of unusual infections or exposure to biological agents, and hence, they must have sophisticated containment systems, sterilization apparatus, and pathogen detection instruments in real time. With increasing bioterrorism, governments and health agencies are investing heavily in the upgrade of hospital biosafety facilities, such as Class III biological safety cabinets, mobile isolation units, and UV sterilization technology, all of which are becoming essential for modern biodefense infrastructure. These facilities need safe conditions to work with high-risk pathogens, which fuels the demand for low-temperature sterilizers, decontamination chambers, and air purification. The growing incorporation of digital surveillance platforms and smart biodefense technologies in healthcare facilities further solidifies their role in early detection and quick response, making hospitals & medical institutes the largest application segment of the biodefense market. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period. Based on technology, the AI technologies segment is projected to register the highest CAGR during the forecast period due to its significant contributions toward monitoring real-time pathogens, forecasting, and fast decision-making. AI facilitates the convergence and synthesis of large-scale environmental data and enables early threat detection and quick response coordination. Governments and health organizations globally are increasingly using AI platforms to track bio-threats across borders and to automatically report disease transmission for strategic purposes. Additionally, AI technologies are being integrated into biosensor networks, autonomous disinfecting robots, and predictive modeling applications utilized in hospitals, airports, and military bases. The increasing focus on digitally empowered biodefense infrastructure, coupled with significant investments by public and private sectors, is expected to fuel the growth of the AI segment in the global market. Asia Pacific is projected to register the highest CAGR during the forecast period. Asia Pacific is projected to register the highest CAGR in the biodefense market through the forecast period due to increasing investments in public health infrastructure, infectious disease surveillance, and military biosafety capacities. China, India, Japan, and Australia are comprehensively developing their biodefense capabilities. These countries are investing in mobile biosafety laboratories, near-real-time pathogen detection systems, and next-generation decontamination technologies to anticipate future biological threats. Also, the region is experiencing growth in biotechnology R&D, cross-border health security efforts, and government-backed biodefense programs. The growth of local biotech and med-tech firms is also propelling innovation in AI-powered disease monitoring, biosensors, and portable sterilizers for civilian and military applications. The growing population, susceptibility to zoonotic disease, and proactive policy changes are driving significant growth in the regional biodefense market. STERIS (US), ASP International GmbH (a subsidiary of Fortive) (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the major key players in the Biodefense Companies. These companies have strong distribution networks across regions like North America, Europe, Asia Pacific, and the Rest of the World. About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook.
